title: Plant virus expression vectors set the stage as production platforms for biopharmaceutical proteins.
abstract: Transgenic plants present enormous potential as a cost-effective and safe platform for large-scale production of vaccines and other therapeutic proteins. A number of different technologies are under development for the production of pharmaceutical proteins from plant tissues. One method used to express high levels of protein in plants involves the employment of plant virus expression vectors. Plant virus vectors have been designed to carry vaccine epitopes as well as full therapeutic proteins such as monoclonal antibodies in plant tissue both safely and effectively. Biopharmaceuticals such as these offer enormous potential on many levels, from providing relief to those who have little access to modern medicine, to playing an active role in the battle against cancer. This review describes the current design and status of plant virus expression vectors used as production platforms for biopharmaceutical proteins.
authors.affiliation: Cell and Systems Biology, University of Toronto, Toronto, Ontario, Canada M5G 3B2. Kathleen.hefferon@utoronto.ca
authors.forename: Kathleen Laura
authors.initials: KL
authors.lastname: Hefferon
mesh_terms: D000911:Antibodies, Monoclonal / Q000096:biosynthesis* / Q000235:genetics / Q000276:immunology; D017798:Comovirus / Q000235:genetics; D000939:Epitopes / Q000235:genetics / Q000276:immunology; D017791:Geminiviridae / Q000235:genetics; D005822:Genetic Vectors; D006801:Humans; D010944:Plants / Q000235:genetics* / Q000378:metabolism / Q000821:virology; D017863:Potexvirus / Q000235:genetics; D011994:Recombinant Proteins / Q000096:biosynthesis* / Q000235:genetics / Q000276:immunology; D014027:Tobacco Mosaic Virus / Q000235:genetics; D014614:Vaccines, Synthetic / Q000096:biosynthesis* / Q000235:genetics / Q000276:immunology
chemical_list: D000911:Antibodies, Monoclonal; D000939:Epitopes; D011994:Recombinant Proteins; D014614:Vaccines, Synthetic